본문 바로가기
KERD
논문KCI 등재

Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Development of hepatocellular carcinoma (HCC) is driven by a multistep and long-term process. Because current therapeutic strategies are limited for HCC patients, there are increasing demands for understanding of immunotherapy, which has made technological and conceptual innovations in the treatment of cancer. Here, I discuss HCC immunotherapy in the view of interaction between liver resident cells and immune cells.

Abstract

Development of hepatocellular carcinoma (HCC) is driven by a multistep and long-term process. Because current therapeutic strategies are limited for HCC patients, there are increasing demands for understanding of immunotherapy, which has made technological and conceptual innovations in the treatment of cancer. Here, I discuss HCC immunotherapy in the view of interaction between liver resident cells and immune cells.

참고문헌 (52)

  1. Almand B, "Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer", J Immunol, 166, pp.678~689 (2001)
  2. Bandyopadhyay K, "NKT cell subsets as key participants in liver physiology and pathology", Cell Mol Immunol, 13, pp.337~346 (2016)
  3. Benetti A, "Transforming growth factor-β1 and CD105 promote the migration of hepatocellular carcinoma–derived endothelium", Cancer Res, 68, pp.8626~8634 (2008)
  4. Bu L, "Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment", Oncogene, 38, pp.4887~4901 (2019)
  5. Chen MM, "Polarization of tissue-resident TFH-like cells in human hepatoma bridges innate monocyte inflammation and M2b macrophage polarization", Cancer Discov, 6, pp.1182~1195 (2016)
  6. Deng Y, "Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells", Oncogene, 36, pp.1090~1101 (2017)
  7. Dudley AC, "Tumor endothelial cells", Cold Spring Harb Perspect Med, 2, pp.a006536~ (2012)
  8. El-Serag HB, "Hepatocellular carcinoma", N Engl J Med, 365, pp.1118~1127 (2011)
  9. El–Serag HB, "Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
  10. Fridlender ZG, "Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN", Cancer Cell, 16, pp.183~194 (2009)
  11. Friedman SL, "Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver", Physiol Rev, 88, pp.125~172 (2008)
  12. Fu J, "Increased regulatory T cells correlate with CD8T-cell impairment and poor survival in hepatocellular carcinoma patients", Gastroenterology, 132, pp.2328~2339 (2007)
  13. Fu Y, "From bench to bed: The tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma", J Exp Clin Cancer Res, 38, pp.396~ (2019)
  14. Gao Q, "Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection", J Clin Oncol, 25, pp.2586~2593 (2007)
  15. Garnelo M, "Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma", Gut, 66, pp.342~351 (2017)
  16. Hoechst B, "Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor", Hepatology, 50, pp.799~807 (2009)
  17. Hou J, "The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications", J Hepatol, 72, pp.167~182 (2020)
  18. Hu CE, "Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function", Scand J Gastroenterol, 46, pp.156~164 (2011)
  19. Huang Y, "The role of tumor associated macrophages in hepatocellular carcinoma", J Cancer, 12, pp.1284~1294 (2021)
  20. Jiang R, "Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3", Hepatology, 54, pp.900~909 (2011)
  21. Kalathil S, "Higher frequencies of GARP+CTLA-4+Foxp3+ T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality", Cancer Res, 73, pp.2435~2444 (2013)
  22. Kang TW, "Senescence surveillance of pre-malignant hepatocytes limits liver cancer development", Nature, 479, pp.547~551 (2011)
  23. Khomich O, "Metabolic hallmarks of hepatic stellate cells in liver fibrosis", Cells, 9, pp.24~ (2019)
  24. Kitamura T, "Immune cell promotion of metastasis", Nat Rev Immunol, 15, pp.73~86 (2015)
  25. Kumar V, "The nature of myeloid-derived suppressor cells in the tumor microenvironment", Trends Immunol, 37, pp.208~220 (2016)
  26. Leliefeld PHC, "How neutrophils shape adaptive immune responses", Front Immunol, 6, pp.471~ (2015)
  27. Llovet JM, "Sorafenib in advanced hepatocellular carcinoma", N Engl J Med, 359, pp.378~390 (2008)
  28. Lu C, "Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: Challenges and opportunities", Mol Cancer, 18, pp.130~ (2019)
  29. Mace TA, "Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner", Cancer Res, 73, pp.3007~3018 (2013)
  30. Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)
  31. McPherson S, "Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease", J Hepatol, 60, pp.1055~1062 (2014)
  32. Mougiakakos D, "Chapter 3 -Regulatory T cells in cancer", Adv Cancer Res, 107, pp.57~117 (2010)
  33. Murdoch C, "Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues", Blood, 104, pp.2224~2234 (2004)
  34. Murdoch C, "The role of myeloid cells in the promotion of tumour angiogenesis", Nat Rev Cancer, 8, pp.618~631 (2008)
  35. Ormandy LA, "Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma", World J Gastroenterol, 12, pp.3275~3282 (2006)
  36. Ormandy LA, "Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma", Cancer Res, 65, pp.2457~2464 (2005)
  37. Pham L, "The functional roles of immune cells in primary liver cancer", Am J Pathol, 192, pp.826~836 (2022)
  38. Rombouts K, "The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma", Fibrogenesis Tissue Repair, 6, pp.17~ (2013)
  39. Shalapour S, "Inflammationinduced IgA+ cells dismantle anti-liver cancer immunity", Nature, 551, pp.340~345 (2017)
  40. Tan H, "A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways", Clin Exp Pharmacol Physiol, 44, pp.213~221 (2017)
  41. Teng CF, "Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model", Ther Adv Med Oncol, 12, pp.1758835920922034~ (2020)
  42. Togashi Y, "Regulatory T cells in cancer immunosuppression —Implications for anticancer therapy", Nat Rev Clin Oncol, 16, pp.356~371 (2019)
  43. Villanueva A, "Hepatocellular carcinoma", N Engl J Med, 380, pp.1450~1462 (2019)
  44. Wörns MA, "Immune oncology in hepatocellular carcinoma—Hype and hope", Lancet, 389, pp.2448~2449 (2017)
  45. Wu K, "Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1", programmed death-1 interactions, 2009, pp.69, 8067~8075
  46. Yang JD, "The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets", Semin Cancer Biol, 21, pp.35~43 (2011)
  47. Yang XH, "Increase of CD4+CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma", J Hepatol, 45, pp.254~262 (2006)
  48. Yang Z, "Mast cells mobilize myeloidderived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model", PLoS One, 5, pp.e8922~ (2010)
  49. Zhang JP, "Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients", J Hepatol, 50, pp.980~989 (2009)
  50. Zhou SL, "Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib", Gastroenterology, 150, pp.1646~1658.E17 (2016)
  51. Zhu S, "NKT cells in liver diseases", Front Med, 12, pp.249~261 (2018)
  52. Ziani L, "Alteration of the antitumor immune response by cancerassociated fibroblasts", Front Immunol, 9, pp.414~ (2018)

관련 논문AI추천

이 간행물의 다른 논문 (6건)